RE:RE:newsPandora wrote: gunzod wrote: Ventripoint issues shares in final payment od Debenture interest.
A little different slant:
Ventripoint corrects share issuance from Feb. 10 PR
2021-02-24 16:14 ET - News Release
An anonymous director reports
CORRECTION -- VENTRIPOINT DIAGNOSTICS ISSUES SHARES IN FINAL PAYMENT OF DEBENTURE INTEREST
Ventripoint Diagnostics Ltd. has made a correction to its Feb. 10, 2021, press release. The Company has issued an aggregate of 96,961 shares, rather than the 131,430 shares previously announced, for the final interest payment of $23,274 on convertible debentures issued by the Company on February 6, 2020, replacement Convertible Debentures issued the same date, and Convertible Debentures issued September 11, 2020. The shares will be issued at a deemed price of $.24 per share. Two directors of the Company will receive a total of 30,186 common shares in final payment of $7,245.88 of interest on their debentures.
All convertible debentures have been converted and the Company is debt free.
If they keep issuing new news releases about this same item I am sure others will get as confused as I am. On February 10 they issue a release re issuing 96,961 shares. They then issued a correction at 16:14 today and now they have issued a third release at 21:05 today about the same 96,961 shares. Good thing they know what they are doing!
Ventripoint Diagnostics 96,961 shares for debt
2021-02-24 21:05 ET - Shares for Debt
This is to confirm that the TSX Venture Exchange has accepted for filing the company's proposal to issue 96,961 common shares to settle outstanding debt for $23,274 of final accrued interest owing on the company's convertible debentures.
Insider: Robert Hodkginson, 20,123 shares at 24 cents; George Adams, 10,063 shares at 24 cents
For further details, please refer to the company's news release dated Feb. 10, 2021. The company shall issue a news release when the shares are issued and the debt extinguished.
© 2021 Canjex Publishing Ltd. All rights reserved.